Unchanging premature mortality trends in systemic lupus erythematosus: a general population-based study (1999–2014)

Abstract

This general population-based cohort study suggests that excess mortality has not improved among SLE patients in recent years, remaining greater than double that of comparators, unlike RA during the same period. This highlights a critical unmet need for the development of new therapeutic agents and improved management strategies for SLE and its comorbidities.